《中国期刊全文数据库》收录期刊
《中国核心期刊（遴选）数据库》收录期刊
《中文科技期刊数据库》收录期刊
外科研究与新技术（中英文）

外科研究与新技术 ›› 2019, Vol. 8 ›› Issue (4): 262-264.doi: 10.3969/j.issn.2095-378X.2019.04.012

• 论著 • 上一篇    下一篇

他莫昔芬与阿那曲唑乳腺癌内分泌治疗对于骨代谢水平的影响

王永亮, 柴辉, 赵宏卿, 王怀锦, 褚瑞军, 郭思亮, 翟耀君   

  1. 阳泉市第一人民医院甲状腺乳腺科,阳泉 045000
  • 收稿日期:2019-06-28 出版日期:2019-12-28 发布日期:2020-09-14
  • 作者简介:王永亮(1974—),男,硕士,副主任医师,从事临床乳腺外科疾病;电子信箱:PGWYL1974@163.com

Effects of tamoxifen and anastrazole endocrine therapies for breast canceron bone metabolism

WANG Yongliang, CHAI Hui, ZHAO Hongqing, WANG Huaijin, CHU Ruijun, GUO Siliang, ZHAI Yaojun   

  1. Department of Thyroid Breast, The First People’s Hospital of Yangquan City, Yangquan 045000, China
  • Received:2019-06-28 Online:2019-12-28 Published:2020-09-14

PDF (PC)

453

摘要： 目的 观察分别采用他莫昔芬与阿那曲唑乳腺癌内分泌治疗对于骨代谢水平的影响。方法 择取放疗后接受内分泌治疗的乳腺癌患者150例,随机分为ANA组(阿那曲唑治疗)和TAM组(他莫昔芬治疗)各75例,均治疗12个月。于治疗前后采血检测两组患者血清降钙素(CT)、骨钙素(BGP)、骨碱性磷酸酶(NBAP)水平,使用X线骨密度测量仪检测L2～L4骨密度。结果 两组患者治疗后的CT、NBAP均高于治疗前,而BGP、L2～L4骨密度均低于治疗前(均P<0.01或P<0.05)。治疗后ANA组CT、BGP、NBAP水平均高于TAM组,L2～L4骨密度低于TAM组(均P<0.01)。结论 他莫昔芬与阿那曲唑乳腺癌内分泌治疗对于骨代谢水平均有明显影响,阿那曲唑影响更为明显。

关键词: 他莫昔芬, 阿那曲唑, 乳腺癌, 内分泌治疗, 骨代谢

Abstract: Objective To observe the effects of tamoxifen and anatrazole endocrine therapies for breast cancer on bone metabolism.Methods A total of 150 patients with breast cancer who received endocrine therapy after radiotherapy were divided into anatrazole (ANA) group (n=75) and tamoxifen (TAM) group (n=75).All patients were treated for 12 months.The serum levels of calcitonin (CT), osteocalcin (BGP), and bone alkaline phosphatase (NBAP) were measured before and after treatment.The bone mineral density of L2-L4 was measured by X-ray absorptiometry.Results After treatment, the CT and NBAP of the two groups were higher than those before treatment, while the BGP and L2-L4 bone mineral density were lower (all P<0.01 or P<0.05).After treatment, the levels of CT, BGP, and NBAP in the ANA group were higher than those in the TAM group, while the L2-L4 bone mineral density was lower (P<0.01).Conclusion Both the endocrine therapies using TAM and ANA have significant effects on the levels of bone metabolism, especially ANA.

Key words: Tamoxifen, Anatrazole, Breast cancer, Endocrine therapy, Bone metabolism

中图分类号: